A simple pressure pump, made from balloons and nylon stockings, means more people in more places will be able to test water contaminants and blood samples.
The ingenious device unveiled in the prestigious Lab on a Chip journal cost just $2 to make, yet works almost as well as its expensive and cumbersome lab counterparts.
Pumps are used to make biological samples flow through microfluidic devices while their contents are identified beneath a microscope.
This DIY pump came from a collaboration between researchers at RMIT University and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, who demonstrated its viability in tests to detect aquatic parasites and cancer cells and to study vascular diseases.
Inspired by football
Study lead author and RMIT engineer, Dr Peter Thurgood,said the team took inspiration for the simple invention from footballs, which hold large pressures when reinforced.
“We started with basic latex balloons, then realised that regular stockings made from nylon and elastane could be a perfect match to reinforce them, allowing them to hold significantly higher pressure and function as pumps,” Thurgood said.
“By simply wrapping three layers of stockings around the latex balloon we were able to increase its internal pressure by a factor of 10 – enough to run many water or blood analyses that would usually require large, expensive pumps.”
Experiments showed the reinforced balloon pump could be used to operate microfluidic devices for several hours without a significant pressure loss.
The pump also fits easily within an incubator and can be left overnight.
A low-cost field tool where it’s needed most
Study co-author and parasitologist at the Walter and Eliza Hall Institute,Associate Professor Aaron Jex, is a leading researcher in global water quality and public health interventions.
He said this simple innovation opened exciting opportunities in field water testing and the ability to test and diagnose patients for infectious pathogens and aquatic micro-organisms at the point-of-care.
“Parasitic micro-organisms have a major impact in impoverished communities in tropical and subtropical regions globally, but also in developed countries including Australia,” Jex said.
“In order to address this there is an urgent need for field-based, low-cost diagnostic tools that work in challenging, sometimes remote and often complex environments very different from a pristine laboratory.”
“As simple as it may look, this device suits those needs really well and could have a big impact.”
Co-author and RMIT biologist, Dr Sara Baratchi, said it also had promising applications for early diagnosis of diseases at home or in the doctor’s surgery.
The balloon pump was tested as a point-of-care diagnostic device for detection of very low concentrations of target cancer cells in liquid samples, and found to work.
“The hydrodynamic force of liquid produced by the reinforced balloon was enough to isolate cells for study, which was really amazing for a $2 pump!”
Baratchi is now working on applying the simplified pump technology to develop organ-on-chip systems that mimic the flow conditions in dysfunctional vessels, to better understand diseases like atherosclerosis that lead to heart attack and stroke.
An opportunity for outreach
RMIT engineer and project leader, Dr Khashayar Khoshmanesh,is a leading researcher in the field of microfluidic based lab-on-a-chip technologies.
He said while microfluidics had made significant progress over the past decade, their widespread application had been limited by the cost and bulk of pumps required to operate them.
“Simplicity is at the heart of our entire research program. By redesigning sophisticated microfluidic devices into simplified ones, we can maximise their outreach and applications for use in teaching or research in the field, not just in sophisticated labs,” he said.
“We envisage these types of pumps also being suitable for student classwork experiments to support capability development in this important area of research from an earlier stage.”
The Latest on: Point-of-care diagnostic device
via Google News
The Latest on: Point-of-care diagnostic device
- WHO endorses Truenat molecular diagnostic tests for TBon July 3, 2020 at 6:32 am
The Foundation for Innovative New Diagnostics, Molbio Diagnostics and the Indian Council of Medical Research announced today that the World Health Organization has now endorsed three of their rapid ...
- Diagnostics firm Eurofins launches new coronavirus test deviceson June 30, 2020 at 10:44 pm
French diagnostics company Eurofins Technologies announced on Wednesday the launch of new devices aimed at testing for the presence of COVID-19, the respiratory disease caused by the coronavirus.
- Eurofins Technologies Launches Rapid Point-of-Care Testing Devices That Identify Exposure to COVID-19 in Only 10 Minuteson June 30, 2020 at 10:30 pm
Regulatory News: Eurofins Technologies (Paris:ERF) announces the launch of CE-IVD marked rapid point-of-care testing devices to identify a person’s pa ...
- Meet the 5 diagnostics finalists for INVEST Pitch Perfect contest. Register now to get the Earlybird rate.on June 30, 2020 at 1:03 pm
In the diagnostics track of the online pitch contest, five companies will present their technologies, which span early detection of pancreatic cancer to liquid biopsies. Register now!
- Tuberculosis Diagnostics Market – Tuberculosis diagnostics devices are proving to be beneficial for rapid COVID-19 testingon June 29, 2020 at 10:44 pm
The tuberculosis diagnostics market may experience a meteoric rise in the growth rate during the forecast period of 2019-2029 with various initiatives and ...
- COVID-19 Diagnostics Market Segmented by Application and Geography Trends, Growth and Forecasts to 2030on June 29, 2020 at 1:44 pm
This press release was orginally distributed by SBWire New York, NY -- ( SBWIRE) -- 06/29/2020 -- COVID-19 diagnostics are the emerging diagnostic sets that are increasingly delivered to medical ...
- NASDAQ:CEMI Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Chembio Diagnostics, Inc.on June 29, 2020 at 9:33 am
A lawsuit was filed on behalf of investors in Chembio Diagnostics, Inc. (NASDAQ:CEMI) shares over alleged securities laws violations. This press release was orginally distributed by SBWire San Diego, ...
- Tangen Biosciences Awarded a Contract for Point-of-Care Detection of Candida aurison June 29, 2020 at 4:34 am
New York State Department of Health’s Wadsworth Center in conjunction with Health Research Inc. to develop a point-of-care device for detection of Candida auris, a “superbug” that is resistant to anti ...
- Outlook into the Ultrasound Devices Worldwide Market to 2026 - Drivers and Restraintson June 25, 2020 at 9:30 am
The "Global Ultrasound Devices Market Analysis 2020" report has been added to ResearchAndMarkets.com's offering. The Global Ultrasound ...
- Purdue University, Raytheon BBN Technologies, PortaScience, Cortex Design, and LaDuca partner on COVID-19 point-of-care test kiton June 25, 2020 at 7:12 am
Purdue University, Raytheon BBN Technologies, PortaScience Inc., Cortex Design Inc., and LaDuca LLC on Wednesday (June 24) announced a partnership to produce and manufacture a COVID-19 home test. The ...
via Bing News